Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 22, 2016

HER2-Targeted Therapy Not Effective in Patients Screened With PRO Onc Assay

Breast Cancer Research and Treatment

 

Additional Info

Disclosure statements are available on the authors' profiles:

Breast Cancer Research and Treatment
Use of a Multiplexed Immunoassay (PRO Onc Assay) to Detect HER2 Abnormalities in Circulating Tumor Cells of Women With HER2-Negative Metastatic Breast Cancer: Lack of Response to HER2-Targeted Therapy
Breast Cancer Res Treat 2016 Sep 08;[EPub Ahead of Print], JD Hainsworth, PB Murphy, JR Alemar, BR Daniel, RR Young, DA Yardley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading